Patents expiring in 2042

US 11542326

Anti-IL-25 antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11542290

Phenothiazine derivatives and uses thereof

CAMP4 Therapeutics Corporation · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11542304

Multimeric bicyclic peptide ligands

BicycleTx Limited · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11542410

Coatings containing enzyme for stable self-cleaning of organic stains

Regents of the University of Minnesota · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11542504

Compounds and methods for modulating ATXN1

Ionis Pharmaceuticals, Inc. · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11542248

Methods and compositions for inhibiting the interaction of menin with MLL proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11541002

Oral film compositions and dosage forms having precise active dissolution profiles

Aquestive Therapeutics, Inc. · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11541032

Composition containing sumo inhibitor and application

CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

AR 123726

DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA Y TIENO[3,2-H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Wed Jan 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

CY 2022006

ΠΡΟΦΑΡΜΑΚΑ ΦΟΥΜΑΡΙΚΩΝ ΑΛΑΤΩΝ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΣΤΗΝ ΑΓΩΓΗ ΠΟΙΚΙΛΩΝ ΝΟΣΩΝ

ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu Jan 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)